Allen David R 4
Research Summary
AI-generated summary
Marimed (MRMD) Director David R. Allen Converts RSUs, Disposes 75,000 Shares
What Happened David R. Allen, a director of Marimed Inc. (MRMD), had RSUs convert into common stock and an offsetting disposition on June 12, 2026. The Form 4 shows an acquisition of 75,000 shares at $0.00 (conversion/exercise of a derivative, code M) and a simultaneous disposition of 75,000 shares at $0.00 (derivative). The reported price for both entries is $0.00, which reflects conversion/settlement of RSUs rather than a cash purchase price; no cash value is reported on the Form 4 entries provided.
Key Details
- Transaction date: 2026-06-12
- Transaction types/codes: M = exercise/conversion of derivative (RSU conversion reported as acquisition and derivative disposition)
- Shares: 75,000 acquired at $0.00; 75,000 disposed at $0.00
- Shares owned after transaction: Not specified in the supplied filing
- Footnotes: F1 — RSUs convert to common stock on a one-for-one basis. F2 — These RSUs were originally granted on June 12, 2025 and there are no RSUs remaining under that grant per the award agreement.
- Timeliness: Report filed on 2026-06-12 (same day), indicating a timely filing.
Context Code M in Form 4 filings generally denotes the exercise or conversion of a derivative security (here, RSUs converting to shares). The $0.00 price typically indicates conversion/settlement rather than a cash purchase; the filing does not state the reason for the simultaneous disposition (e.g., sale, transfer, or tax-withholding). These transactions are informational for investors but do not by themselves indicate management’s market view.